S100A8 and inflammatory bowel disease: S100A8/A9 has become a widespread biomarker used in the diagnosis and monitoring of inflammatory bowel disease (IBD) [7] and has been proposed as a potential biomarker for psoriasis and psoriasis arthritis (PsA) [8, 9].